E H Sasso
Overview
Explore the profile of E H Sasso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jurgens M, Safy-Khan M, de Hair M, Bijlsma J, Welsing P, Tekstra J, et al.
Arthritis Res Ther
. 2020 Sep;
22(1):205.
PMID: 32907614
Objectives: The CAMERA-II trial compared two tight-control, treat-to-target strategies, initiating methotrexate with prednisone (MTX+pred) or MTX with placebo (MTX+plac), in early RA-patients. The multi-biomarker disease activity (MBDA) blood test objectively...
2.
Ma M, Defranoux N, Li W, Sasso E, Ibrahim F, Scott D, et al.
Arthritis Res Ther
. 2020 Jun;
22(1):158.
PMID: 32580789
Background: Reliable assessment of remission is important for the optimal management of rheumatoid arthritis (RA) patients. In this study, we used the multi-biomarker disease activity (MBDA) test to explore the...
3.
Boyd T, Eastman P, Huynh D, Qureshi F, Sasso E, Bolce R, et al.
Expert Rev Clin Immunol
. 2020 Feb;
16(3):335-341.
PMID: 32067517
: To assess the correlation of serum protein biomarkers with disease activity across different domains of psoriatic arthritis (PsA).: A cross-sectional cohort of 45 adult patients with PsA fulfilling the...
4.
Brahe C, Ostergaard M, Johansen J, Defranoux N, Wang X, Bolce R, et al.
Scand J Rheumatol
. 2018 Jul;
48(1):9-16.
PMID: 29985080
Objectives: Measurement of serum biomarkers at disease onset may improve prediction of disease course in patients with early rheumatoid arthritis (RA). We evaluated the multi-biomarker disease activity (MBDA) score and...
5.
Krabbe S, Bolce R, Brahe C, Dohn U, Ejbjerg B, Hetland M, et al.
Scand J Rheumatol
. 2016 Sep;
46(5):353-358.
PMID: 27682742
Objectives: To investigate the multi-biomarker disease activity (MBDA) score by comparison with imaging findings in an investigator-initiated rheumatoid arthritis (RA) trial (HURRAH trial, NCT00696059). Method: Fifty-two patients with established RA...
6.
Segurado O, Sasso E
Clin Exp Rheumatol
. 2014 Nov;
32(5 Suppl 85):S-29-34.
PMID: 25365086
Quantitative and regular assessment of disease activity in rheumatoid arthritis (RA) is required to achieve treatment targets such as remission and to optimize clinical outcomes. To assess inflammation accurately, predict...
7.
Papp K, Menter A, Poulin Y, Gu Y, Sasso E
J Eur Acad Dermatol Venereol
. 2012 Mar;
27(5):634-42.
PMID: 22429586
Background: REVEAL was a 52-week study of adalimumab for moderate to severe psoriasis. At Week 33, adalimumab-treated patients with sustained responses (PASI ≥75 at Weeks 16 and 33) were re-randomized...
8.
Saurat J, Langley R, Reich K, Unnebrink K, Sasso E, Kampman W
Br J Dermatol
. 2011 May;
165(2):399-406.
PMID: 21564071
Background: CHAMPION was a phase III trial that compared adalimumab with methotrexate and placebo for chronic plaque psoriasis. Objectives: To determine the relationship between methotrexate dosing and improvement in psoriasis...
9.
Sasso E, Merrill C, Furst T
Ther Apher
. 2001 May;
5(2):84-91.
PMID: 11354304
Studies of the humoral effects of the Prosorba column were conducted in conjunction with the Phase 3 trial of Prosorba versus sham therapy for rheumatoid arthritis (RA). When perfused with...
10.
Sasso E, Ghillani P, Musset L, Piette J, Cacoub P
Clin Exp Immunol
. 2001 Feb;
123(1):88-93.
PMID: 11168003
Monoclonal IgM in type II mixed cryoglobulins (MC) preferentially use 51p1-related immunoglobulin VH genes. In normal preimmune B lymphocytes, 51p1-related gene expression is proportional to the germ-line gene dosage, which...